HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 232 filers reported holding HORIZON PHARMA PLC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,524,000 | +28.0% | 57,655 | -5.4% | 0.05% | +40.5% |
Q4 2018 | $1,191,000 | -13.3% | 60,975 | -13.1% | 0.04% | +12.1% |
Q3 2018 | $1,374,000 | -0.5% | 70,180 | -15.9% | 0.03% | -2.9% |
Q2 2018 | $1,381,000 | -3.3% | 83,400 | -17.1% | 0.03% | +6.2% |
Q1 2018 | $1,428,000 | +0.3% | 100,560 | +4.3% | 0.03% | +28.0% |
Q1 2017 | $1,424,000 | -59.7% | 96,375 | -55.9% | 0.02% | -55.4% |
Q4 2016 | $3,535,000 | +74.6% | 218,495 | +95.6% | 0.06% | +100.0% |
Q3 2016 | $2,025,000 | -39.7% | 111,685 | -45.2% | 0.03% | -39.1% |
Q2 2016 | $3,358,000 | -0.7% | 203,910 | -0.1% | 0.05% | +9.5% |
Q1 2016 | $3,382,000 | +2.5% | 204,125 | +34.0% | 0.04% | +16.7% |
Q4 2015 | $3,301,000 | +119.2% | 152,340 | +100.4% | 0.04% | +125.0% |
Q3 2015 | $1,506,000 | -76.0% | 76,005 | -57.9% | 0.02% | -70.4% |
Q2 2015 | $6,268,000 | -56.0% | 180,450 | -67.1% | 0.05% | -52.2% |
Q1 2015 | $14,251,000 | +18.9% | 548,755 | -41.0% | 0.11% | +27.0% |
Q4 2014 | $11,984,000 | +10.5% | 929,750 | +5.3% | 0.09% | +12.7% |
Q3 2014 | $10,841,000 | – | 882,850 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |